🔴 Conexeu Sciences is trading 7.46% down today amid broad U.S. equity and biotech pressure

Conexeu Sciences is trading 7.46% down now at $6.64 after broader risk-off pressure hit U.S. equities and biotechnology shares on September 1, 2026.

• The S&P 500 is down 0.63%, while the Nasdaq Composite is down 1.03%.
• Biotech ETF XBI is down 4.24%, creating a challenging backdrop for this volatile early-stage biotechnology stock.
• No clear company-specific announcement has been identified for September 1; the latest company update predates the decline.